Imprimis NJOF, LLC recalls

All Imprimis NJOF, LLC recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (7).

7 recalls published between April 9, 2025 and January 14, 2026. Most common issues: potency (4).

• Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL)… recall
  FDA January 14, 2026 · Imprimis NJOF, LLC · Class II
• Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL… recall
  FDA January 14, 2026 · Imprimis NJOF, LLC · Class II
• Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL… recall
  FDA January 14, 2026 · Imprimis NJOF, LLC · Class II
• Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic… recall
  FDA November 26, 2025 · Imprimis NJOF, LLC · Class III
• Tropicamide-Proparacaine-Phenylephrine-Ketorolac… recall
  FDA July 30, 2025 · Imprimis NJOF, LLC · Class III
• Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL… recall
  FDA July 30, 2025 · Imprimis NJOF, LLC · Class II
• Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic… recall
  FDA April 9, 2025 · Imprimis NJOF, LLC · Class III